David Icke, CEO. Dave Icke joined mc10 as CEO in March 2009. Before joining mc10, Dave spent almost twenty years in the semiconductor industry in marketing, process and product development, applications, and general management roles with Cypress Semiconductor, KLA-Tencor, and Teradyne. While at Teradyne, a leading supplier of automated test equipment, Dave ran the Wireless and Consumer Business Units within the Semiconductor Test Division, with responsibility for annual sales of up to $500M. Before Teradyne, Dave held a series of customer-focused roles over eleven years with KLA-Tencor, the leading supplier of process control solutions for semiconductor manufacturing, including VP of Marketing for the Wafer Inspection Division, KLA-Tencor's largest business. He began his professional career at Cypress Semiconductor as a lithography Process Development Engineer. Dave also spent three years commercializing breakthrough technology with Advanced Electron Beams, a venture-backed startup providing a clean, efficient form of energy for industrial processing to the pharmaceutical, medical device, and beverage industries. Dave has a passion for building great teams, commercializing innovative technologies, and introducing new products that enable customers to change the way they do business. Dave has a B.S. degree in Chemical Engineering from Stanford University, and an M.B.A. degree from Harvard Business School.

Jeffrey Carbeck, CTO. Jeff joined mc10 as the CTO in September of 2009. Prior to his career as an entrepreneur, he was a faculty member in the Department of Chemical Engineering at Princeton. In 2006 he left academics and joined Nano-Terra as its Chief Scientist and also co-founded Arsenal Medical and served as its Chief Technology Officer. In 2009 he was a Clean Energy Fellow with the New England Clean Energy Council. Soon after starting his career as an entrepreneur, the Boston Business Journal recognized him as one of the 40 outstanding professionals under the age of 40. Jeff serves on the Advisory Boards of Arsenal Medical and NanoTerra, and the University of Michigan’s Department of Materials Science and Engineering. He attended the University of Michigan (BSE), MIT (PhD), and Harvard for two years of post-doctoral research with George Whitesides.

Benjamin Schlatka, VP of Business Development, co-Founder. Prior to mc10, Ben was the Director of Business Development for Nantero, a venture funded nanotechnology startup, where he was responsible for creating development partnerships around Nantero’s core technology. In 2008, Lockheed Martin Corporation purchased Nantero’s carbon nanotube electronics business for military and aerospace applications. Earlier in his career he was instrumental in launching a new business unit for IBM Microelectronics servicing network hardware providers. He also led marketing and sales for VolunteerSolutions.org, winner of the 1998 MIT 50K, which he sold to the United Way in 2001. Mr. Schlatka holds an MBA from the Harvard Business School and specializes in semiconductor and electronic materials businesses.

Kevin Dowling, VP of Research & Development. Kevin joined mc10 as the VP of R&D in January of 2010. Prior to mc10, Kevin was VP of Innovation at Philips Color Kinetics where he oversaw many programs and initiatives designed to keep Color Kinetics at the forefront of LED lighting. Previously he built and led the engineering team at Color Kinetics and was active in a variety of strategic roles in technology development, intellectual property, Color Kinetics' IPO in 2004 and acquisition by Philips in 2007 for $800M. He also proposed and led significant programs for the Department of Energy and NIST as well as helping develop the first entrant by Philips for the DoE $10M L-Prize. Kevin actively engaged with government and industry and was co-founder and Chairman of the National Electrical Manufacturers Association (NEMA) Solid-State Lighting Section and the Illuminating Engineering Society (IES) Solid-State Lighting Committee. He was also Chairman of the Next Generation Lighting Industry Alliance (NGLIA). Prior to Color Kinetics, Kevin was Chief Robotics Engineer for PRI Automation, developing advanced factory automation systems for the semiconductor industry. He has over 15 years of experience in advanced robotics engineering at the Robotics Institute at Carnegie Mellon University, where, as a scientist, he led many projects including robotic systems for a Lunar Rover demo, Space Shuttle inspection at NASA's Kennedy Space Center, and the Mars Rover Project. He holds 60 U.S. Patents and is the recipient of numerous awards and fellowships. Kevin received his BS in Mathematics and MS and Ph.D. degrees in Robotics from Carnegie Mellon University.

Carmichael Roberts, Chairman. Carmichael joined North Bridge Venture Partners in 2007. Prior to joining North Bridge, he co-founded and served as the President and Chief Executive Officer of Arsenal Biomedical, Inc. Before Arsenal Biomedical, Carmichael co-founded and served as the President and Chief Executive Officer of Surface Logix, Inc., a drug optimization company. Carmichael has also co-founded and served as a director of several other ventures, including Ancora Pharmaceuticals, Inc., a carbohydrate materials company, Nano-Terra, Inc., an electronics and industrial materials company, and Diagnostics For All, Inc., a non-profit organization that is developing a materials platform to make low cost diagnostics for the poor. Carmichael is mainly interested in companies that make products using chemistry, materials science and/or materials engineering. He primarily focuses on very early stage ventures, including helping founders launch companies from initial formation. Carmichael received his B.S. and Ph.D. in organic chemistry from Duke University and completed his postdoctoral fellowship at Harvard University. Carmichael also received his M.B.A. from the MIT Sloan School of Management.

Jiong Ma, Partner at Braemar Energy Ventuers. Jiong has more than 14 years of research, operating and venture capital experience in the technology industry. Prior to joining Braemar, she was with the venture group at 3i, a global private equity firm. At 3i, Dr. Ma was responsible for investment in the information technology and cleantech sectors. Prior to 3i, Dr. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development, where she led projects in defining product features, system architecture, network design and operations. Dr. Ma was also a founding team member of Onetta, a fiber networks start-up company, and a technical staff member of Nortel Networks. Dr. Ma received a Ph.D. in electrical engineering from the University of Colorado at Boulder, an M.S. in electrical engineering from the Worcester Polytechnic Institute in Massachusetts, and a B.S. in physics from Lanzhou University, China. She is a graduate of the Kauffman Fellows Program, has published or co-authored 15 technical papers, and holds one U.S. patent. Dr. Ma serves on the board of Convey Computer, Fulham and Laser Light Engines and Powervation, and is a board observer at Luminus Devices.

Paul Klingenstein, Managing Partner at Aberdare Ventures, has been a venture capital investor focused on healthcare innovation and young companies for most of his professional career. Beginning at Warburg, Pincus in the early 1980s, he joined Accel Partners in 1986 and helped, through the next decade, to build a leading venture capital firm. After a brief period as an advisor to the Rockefeller Foundation, he formed Aberdare Ventures in 1999. During this time he has invested in more than 50 companies, the majority of which are now public or have been merged into public companies. Working closely with management teams (some very experienced and some very inexperienced; but all incomplete), he tends to focus on financing and product strategy, recruiting, and partnering. These investments comprise mostly early-stage domestic businesses, but also include later-stage, public, non-U.S. companies, and management buyouts. His current and former boards include Ablation Frontiers, Alibris (former Chair), Ample Medical, Anacor Pharmaceuticals, Aviir, Aviron, Clovis Oncology, Conatus Pharmaceuticals, EP Technologies, EnteroMedics, Glycomed, Idun Pharmaceuticals, Isis Pharmaceuticals, Nevro, Pharmion, Posit Science, U.S. Behavioral Health, VertiFlex, Viagene, and Xomed Surgical Products. He has served on the boards of various educational and non-profit institutions including the African Wildlife Foundation, Juma Ventures (former Chair), UC-Berkeley School of Public Health Policy Advisory Council, the Marin Country Day School and the Taft School. He is currently the Chairman of the Board of the International AIDS Vaccine Initiative, a global organization which supports science, clinical testing, advocacy, and policy in support of an HIV vaccine. He received an AB from Harvard and an MBA from Stanford.

Marc Singer, Managing Partner at Osage Partners. Marc joined Osage in 2008 as a fifteen year veteran in venture capital industry. Marc was previously a General Partner of BEV Capital, an early stage venture capital firm he co-founded in 1997. Over the last ten years Marc helped BEV raise and invest over $200M in over 40 companies and co-invested with over 100 other venture capital firms. Marc managed or co-managed eighteen of BEV's investments, served as an active board member and/or Chairman for the majority of his investments, and successfully managed multiple companies from start-up through IPO or trade sale. Prior to co-founding BEV in 1997, Marc worked at Consumer Venture Partners, another venture capital firm which he joined in 1993. Marc earned his BS from The Wharton School of the University of Pennsylvania.

John Rogers, co-founder. Prof. Rogers is the Lee J. Flory-Founder Chair Professor of Engineering at the University of Illinois, Urbana-Champaign, where he is also affiliated with the Beckman Institute and the Materials Research Laboratory, as well as the Departments of Electrical and Computer Engineering, Mechanical Science and Engineering, and Chemistry. John has been involved in several early stage companies, including Active Impulse Systems, which he founded and successfully exited. Prior to UIUC he was the former Director of Condensed Matter Physics Research at Bell Laboratories. John has published over 235 papers and holds nearly 70 patents, more than 40 of which are licensed or in active use. John's honors include: MacArthur Fellowship for his work in unusual format electronics, optoelectronics, and photovoltaics (2009); top 10 technologies of the year, by MIT's Technology Review magazine (2009, 2005 and 2003); top 50 scientists of the year, by Scientific American (2005); Harvard University Robert B. Woodward Scholar (2001). He is a Fellow of the American Association for the Advancement of Science, the Materials Research Society, the Institute for Electrical and Electronics Engineers and the American Physical Society. John recieved a B.S. in Physics and B.A. in Chemistry from the University of Texas at Austin, a Ph.D. in Physical Chemistry from MIT, and was a Junior Fellow of the Society of Fellows at Harvard.

David Icke, CEO. Dave Icke joined mc10 as CEO in March 2009. Before joining mc10, Dave spent almost twenty years in the semiconductor industry in marketing, process and product development, applications, and general management roles with Cypress Semiconductor, KLA-Tencor, and Teradyne. While at Teradyne, a leading supplier of automated test equipment, Dave ran the Wireless and Consumer Business Units within the Semiconductor Test Division, with responsibility for annual sales of up to $500M. Before Teradyne, Dave held a series of customer-focused roles over eleven years with KLA-Tencor, the leading supplier of process control solutions for semiconductor manufacturing, including VP of Marketing for the Wafer Inspection Division, KLA-Tencor's largest business. He began his professional career at Cypress Semiconductor as a lithography Process Development Engineer. Dave also spent three years commercializing breakthrough technology with Advanced Electron Beams, a venture-backed startup providing a clean, efficient form of energy for industrial processing to the pharmaceutical, medical device, and beverage industries. Dave has a passion for building great teams, commercializing innovative technologies, and introducing new products that enable customers to change the way they do business. Dave has a B.S. degree in Chemical Engineering from Stanford University, and an M.B.A. degree from Harvard Business School.